Federal contract award
75F40123F19005
THE CONTRACTOR SHALL PROVIDE SCIENTIFIC WRITERS-EDITORS TO SUPPORT DIVISION OF VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY (DVRPA) STAFF WHO HAVE RESPONSIBILITY FOR REVIEW OF REGULATORY SUBMISSIONS AND PREPARATION OF REVIEW MEMORANDA, ADVISORY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541990 — All Other Professional, Scientific, and Technical Services |
| PSC | B529 — Scientific Data Studies |
| Parent award / vehicle | 75F40122D00018 |
| Set-aside | Not reported |
| Pricing type | LABOR HOURS |
| Obligations | $1.9M |
| Current contract value | $1.9M |
| Potential contract value / ceiling | $1.9M |
| Start date | Jun 30, 2023 |
| Current end date | Aug 5, 2025 |
| Potential end date | Aug 5, 2025 |
| Latest award activity | Jul 13, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 13, 2026 | P00005 | $-257.7K | DEOBLIGATION/CLOSEOUT |
| Aug 5, 2025 | P00004 | $0 | THE CONTRACTOR SHALL PROVIDE SCIENTIFIC WRITERS-EDITORS TO SUPPORT DIVISION OF VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY (DVRPA) STAFF WHO HAVE RESPONSIBILITY FOR REVIEW OF REGULATORY SUBMISSIONS AND PREPARATION OF REVIEW MEMORANDA, ADVISORY |
| Dec 17, 2024 | P00003 | $0 | NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO JUNE 30, 2025. |
| Jun 24, 2024 | P00002 | $731.2K | MEDICAL WRITER TO SUPPORT COVID SUBMISSIONS AND COVID RELATED WORK. |
| Jan 4, 2024 | P00001 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO CHANGE THE COMPANY NAME FROM KAIVA TO KAIVA STRATEGIES LLC. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Jun 30, 2023 | 0 | $1.4M | THE CONTRACTOR SHALL PROVIDE SCIENTIFIC WRITERS-EDITORS TO SUPPORT DIVISION OF VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY (DVRPA) STAFF WHO HAVE RESPONSIBILITY FOR REVIEW OF REGULATORY SUBMISSIONS AND PREPARATION OF REVIEW MEMORANDA, ADVISORY |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.